32 results on '"Figueiredo-Pontes, Lorena Lôbo"'
Search Results
2. Microcosting analysis of haematopoietic stem cell transplantation and chemotherapy with intermediate doses of cytarabine in the treatment of acute myeloid leukaemia
3. Phenformin increases early hematopoietic progenitors in the Jak2V617F murine model
4. Philadelphia-negative myeloproliferative neoplasms display alterations in monocyte subpopulations frequency and immunophenotype
5. Clinical and molecular profile of a Brazilian cohort of patients with classical BCR-ABL1-negative myeloproliferative neoplasms
6. Philadelphia-negative myeloproliferative neoplasms as disorders marked by cytokine modulation
7. Differential cytotoxic activity of pharmacological inhibitors of IGF1R-related pathways in JAK2V617F driven cells
8. Transcriptional deregulation of LSD1 and LSD2 is associated with cytogenetic risk in chronic lymphocytic leukemia
9. Management of acute colorectal diseases in febrile neutropenic patients
10. Metformin exerts multitarget antileukemia activity in JAK2V617F-positive myeloproliferative neoplasms
11. Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax
12. Phenformin increases early hematopoietic progenitors in the Jak2V617F murine model.
13. The co-expression of PML/RAR α and AML1/ETO fusion genes is associated with ATRA resistance
14. Experience of Generic Imatinib As a First Line Therapy for Patients with Chronic Myeloid Leukemia in a Single Reference Institution
15. The Scenario of Myelofibrosis in Brazil in the View of a Panel of Experts: Challenges and Proposals
16. Reduced SLIT2 Are Associated with Increased Cell Proliferation and Arsenic Trioxide Resistance in APL Cells
17. Efficacy of the Pan-Bcl-2 Inhibitor (Obatoclax) As a Single Agent to Treat Myeloproliferative Neoplasm in JAK2V617F Murine Transplantation Model
18. Identification and Characterization of ALK Kinase Splicing Isoforms in Non–Small-Cell Lung Cancer
19. Abnormal Distribution and Function of NK Cells Subsets May Lead to Impaired Tumor Surveillance in a JAK2V617F Myeloproliferative Neoplasm Model
20. C/Ebpg (CCAAT/Enhancer Binding Protein Gamma) Balances Cytotoxic and Secretory Potential of Natural Killer Cells
21. The Pharmacological IGF1R-IRS1/2 Inhibitor NT157 Presents Multiple Anti-Neoplastic Effects in Myeloproliferative Neoplasms
22. Cytokine-Mediated Natural Killer Cells Effects Impair Hematopoietic Stem Cell Function
23. Insertion (15;14)(q22;q13q32) in a case of Ph+ ALL
24. The Use of Cyclosporine in Association with Chemotherapy As Induction Treatment in Patients with Acute Myeloid Leukemia (AML) and High Rhodamine Efflux at Diagnosis Results in Higher Complete Hematological Remission Rates, but Does Not Prolong Overall Survival
25. Decreased Activity of NK Cells in Myeloproliferative Neoplasms
26. Dysregulation Of Bcl2 Family Proteins Induced By JAK2V617F Mutation Contributes To The Abnormal Expansion Of Neoplastic Initiating Cells
27. Flow Cytometry Quantification of Leukemic Stem Cells Is Associated with Risk Stratification and May Be Useful for Minimal Residual Disease in Acute Myeloid Leukemia
28. Spectral Karyotyping (SKY) ANALYSIS APPLIED to CHRONIC LYMPHOCYTIC LEUKEMIA CELLS Immunostimulated with the COMBINATION DSP30/IL-2.
29. Metformin exerts multitarget antileukemia activity in JAK2V617F-positive myeloproliferative neoplasms.
30. The co-expression ofPML/RARα andAML1/ETOfusion genes is associated with ATRA resistance.
31. Differential cytotoxic activity of pharmacological inhibitors of IGF1R-related pathways in JAK2 V617F driven cells.
32. The co-expression of PML/RAR alpha and AML1/ETO fusion genes is associated with ATRA resistance.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.